García Llana, HelenaPanizo González, NayaraGandía Salmerón, LorenaOrtí, MarisaGiménez Civera, ElenaForquet Daroca, ClaudiaD'Marco Gascón, Luis GerardoUCH. Departamento de Medicina y CirugíaProducción Científica UCH 20222023-06-042023-06-042022-02-16Garcia-Llana, H., Panizo, N., Gandía, L., Orti, M., Giménez-Civera, E., Forquet, C., D'Marco, L., Puchades, M. J., Sargsyan, M., Sanchís, I., Ribera, C., Marco, M. I., Ferrá, C. M., Pérez-Baylach, C. M., Bonilla, B., Moncho Francés, F., Perez-Bernat, E., Sancho, A. & Górriz, J. L. (2022). COVID-19 vaccination improved psychological distress (Anxiety and depression scores) in chronic kidney disease patients: a prospective study. Vaccines, vol. 10, i. 2 (16 feb.), art. 299. DOI: https://doi.org/10.3390/vaccines100202992076-393X (Electrónico)http://hdl.handle.net/10637/14391Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2076-393X/10/2/299En este artículo de investigación también participan: Maria Jesús Puchades, Mari Sargsyan, Irina Sanchís, Carmen Ribera, Ma. Inés Marco, Cristela Moncho Ferrá, Carmen María Pérez-Baylach, Begoña Bonilla, Francesc Moncho Francés, Elisa Perez-Bernat, Asunción Sancho y Jose Luis Górriz.Este artículo pertenece al número especial "Psychological Aspects of COVID-19 Vaccine Uptake: Principles and Empirical Strategies".The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact.application/pdfenopen accessCovid-19 (Disease) - Vaccination.Anxiety.Riñones - Enfermedades.Kidneys - Diseases.Depresión mental.Ansiedad.Riñones - Trasplante.Kidneys - Transplantation.SARS-CoV-2 (Virus)Covid-19 - Vacunación.Depression, Mental.Artículohttps://doi.org/10.3390/vaccines10020299https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es